Darmerkrankungen
- Geschlecht Beides
- Alter von 18 bis 65
- BMI von 18.5 bis 30
- Berechnen Sie Ihren BMI hier
Darmerkrankungen
Clinical trial of a new compound that has been developed for the treatment of bowel diseases
The research physician about this research
In this trial, the new compound will be administered once, directly into the vein. The period of stay in our clinic is followed by short visits for a number of months. The purpose of this trial is to investigate how quickly and to what extent the newly developed compound is absorbed, broken down, and eliminated by the body. This is compared to a similar compound that is already available on the market.
Für Deutschland: Bitte beachten Sie: Die Arzneimittelstudien finden im niederländischen Groningen statt. Sie müssen Englisch oder Niederländisch sprechen, verstehen und lesen können, um an einer Studie teilnehmen zu können.
Important information about this study
- You will receive an interim payment (33% + travel costs) after the 4th short visit
- Relatively few moments of research. Plenty of free time to relax, study or work remotely
- Smokers and non-smokers are allowed to participate in this study
Group 24 | 9 Tage Aufenthalt 18 Mai 2023 bis einschl. 26 Mai 2023 |
kurzer Besuch 28 Mai 2023 2 Jun 2023 16 Jun 2023 30 Jun 2023 21 Jul 2023 11 Aug 2023 1 Sep 2023 |
Nachuntersuchung 22 Sep 2023 |
€ 4.116 |
Group 25 | 9 Tage Aufenthalt 29 Mai 2023 bis einschl. 6 Jun 2023 |
kurzer Besuch 8 Jun 2023 13 Jun 2023 27 Jun 2023 11 Jul 2023 1 Aug 2023 22 Aug 2023 12 Sep 2023 |
Nachuntersuchung 3 Okt 2023 |
€ 4.116 |
Groep 26 | 9 Tage Aufenthalt 6 Jun 2023 bis einschl. 14 Jun 2023 |
kurzer Besuch 16 Jun 2023 21 Jun 2023 5 Jul 2023 19 Jul 2023 9 Aug 2023 30 Aug 2023 20 Sep 2023 |
Nachuntersuchung 11 Okt 2023 |
€ 4.116 |
Group 27 | 9 Tage Aufenthalt 14 Jun 2023 bis einschl. 22 Jun 2023 |
kurzer Besuch 24 Jun 2023 29 Jun 2023 13 Jul 2023 27 Jul 2023 17 Aug 2023 7 Sep 2023 28 Sep 2023 |
Nachuntersuchung 19 Okt 2023 |
€ 4.116 |
Who can participate?
- You are a healthy male or female
- You are between 18 and 65 years old
- Your Body Mass Index (BMI) is between 18.5 and 30.0 kg/m2.
- Both non-smokers and smokers are allowed to participate in this clinical trial. However, smoking is not allowed during your stay in the research facility.
Note:
- You cannot participate in the trial if you have participated in another clinical trial in the 30 days prior to the first administration in this clinical trial (counting from the last administration). This might be longer for certain trials, please contact us for more information.
- To determine if you are suitable to participate in this trial, you will undergo a medical screening. Depending on availability, this can be performed in Groningen or in Utrecht.
As a female you can only participate if you are not pregnant, not breastfeeding, and meet one of the following conditions:
- You are using hormonal contraception (for example the contraceptive pill or intra-uterine device containing hormones);
- You are using a copper intra-uterine device;
- You have passed the menopause (no period for at least 12 months);
- You have been sterilized or your male partner has been sterilized;
- You abstain from (hetero)sexual intercourse (you are not sexually active) according to your lifestyle.
As a male you can only participate if you meet one of the following conditions:
- You are using a condom in combination with a contraception method used by your female partner;
- You have been sterilized or your female partner is sterilized or has passed the menopause;
- You abstain from (hetero)sexual intercourse (you are not sexually active) according to your lifestyle.
Compensation
- You will receive a gross compensation of € 4116 for participation in one of the groups.
- Travel expenses will be reimbursed based on the distance traveled (€ 0,19 net per kilometer) with a minimum of € 12,- and a maximum of € 160,- (840 kilometers) per round trip, regardless of the mode of transportation.
Period of stay and research
The trial consists of 1 period during which you will stay in the research facility in Groningen for 9 days (8 nights), followed by 8 short visits including the follow-up.
PLEASE NOTE: You must be available for all dates to be able to participate in this study.